Healthcare Contract Research Outsourcing Market is Expanding Rampantly with Charles River Laboratories entering into a contract with Takeda Pharmaceutical Company Limited for Drug Discovery
Healthcare contract research (HCRO) refers to the process by which an organization or a firm that provides healthcare services, such as clinical laboratory services contracts research and provides staff and services based on agreed-upon rates with another organization that meets or exceeds those agreed-upon rates. This type of contract is usually for one or more years. This type of contract is normally used when an organization needs to hire staff members that meet specific requirements to meet their organization’s healthcare goals and missions. In addition, research facilities can also contract with healthcare professionals to provide ongoing healthcare training and education for their own staff.
Increasing investment in drug
research and development activities is expected to drive growth of the global
healthcare contract research outsourcing market. Many major companies in the
pharmaceutical sector have started investing significantly in drug development.
Some companies have partnered with research institutes and competitors to
accelerate the R&D activities. For instance, in March 2020, Johnson &
Johnson partnered with the Biomedical Advanced Research and Development
Authority (BARDA) of the U.S. Department of Health and Human Services to fund
US$ 1 billion in COVID-19 vaccine and antiviral treatment R&D. Furthermore,
in May 2019, AstraZeneca inaugurated a new development operations center in
Bangalore, India to support research on oncology, renal and metabolism,
cardiovascular, and respiratory issues. Hence, such factors are expected to
drive growth of the global healthcare contract research outpouring market.
Furthermore, growing preference for outsourcing activities due to cost and time
limitations is expected to propel the global healthcare contract research
outsourcing market growth in the near future.
Stringent regulations on drug
development enforced by governing authorities are expected to restrain growth
of the global healthcare contract research outsourcing market. Among regions,
Asia Pacific is expected to witness significant growth in the global healthcare
contract research outsourcing market. This is owing to high prevalence of
chronic conditions such as asthma and diabetes in the region. According to
Diabetes.co.uk, in 2019, over 30 million people were diagnosed with diabetes in
India. Furthermore, North America is expected to register a lucrative growth
rate, owing to rising government support for R&D activities through grants
in the region.
Major competitors operating in the
global healthcare contract research outsourcing market are ICON plc, Medidata
Solutions, Charles River Laboratories (CRL), Pharmaron, Syneos Health, PAREXEL
International Corporation, IQVIA, Pharmaceutical Product Development, LLC
(PPD), GVK Biosciences Private Limited, and Covance.
For instance, in January 2020,
Charles River Laboratories entered into an agreement with Takeda Pharmaceutical
Company Limited for drug discovery.

Comments
Post a Comment